AlphaQuest’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-752
Closed -$264K 642
2025
Q4
$264K Sell
752
-4,831
-87% -$1.63M 0.01% 1291
2025
Q3
$1.8M Buy
+5,583
New +$1.74M 0.12% 215
2025
Q2
Sell
-424
Closed -$184K 2108
2025
Q1
$184K Sell
424
-64
-13% -$25.7K 0.02% 1037
2024
Q4
$180K Sell
488
-1,831
-79% -$766K 0.02% 902
2024
Q3
$1.21M Buy
2,319
+1,550
+202% +$828K 0.11% 292
2024
Q2
$417K Sell
769
-2,795
-78% -$1.48M 0.06% 521
2024
Q1
$1.85M Sell
3,564
-64
-2% -$31.8K 0.32% 66
2023
Q4
$1.71M Buy
+3,628
New +$1.68M 0.36% 30

Other funds holding ELV

AlphaQuest's ELV Position: Q1 2026 in Review

AlphaQuest sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 752 shares — an estimated $264K sold.

AlphaQuest first reported a position in ELV in Q4 2023 and held it in 8 quarters. The position peaked at $1.85M in Q1 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • AlphaQuest reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 752 Elevance Health shares in Q1 2026, an estimated $264K.
  • AlphaQuest first reported a position in Elevance Health in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's Elevance Health position peaked at $1.85M in Q1 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.